Worldwide Healthcare Trust PLC Edison issues review on Worldwide Healthcare Trust
July 30 2020 - 8:06AM
RNS Non-Regulatory
TIDMWWH
Worldwide Healthcare Trust PLC
30 July 2020
London, UK, 30 July 2020
Edison issues review on Worldwide Healthcare Trust (WWH)
Worldwide Healthcare Trust (WWH) is celebrating its 25th
anniversary. Managed by Sven Borho and Trevor Polischuk at OrbiMed,
the trust has an enviable absolute and relative performance track
record. The managers remain very constructive on the prospects for
the global healthcare sector, suggesting that while President Trump
has once again focused on the issue of US drug pricing, his 'bark
is worse than his bite', and his efforts are a negotiating ploy to
get the healthcare industry to the table to discuss reforms. They
highlight minimal disruptions at the US Food and Drug
Administration (FDA) as a result of the coronavirus and expect an
uptick in industry mergers and acquisitions (M&A) in H220 and
beyond.
WWH's shares regularly trade close to NAV. The current 1.1%
premium to cum-income NAV compares to a range of an average 0.3%
premium to an average 3.8% discount over the past one, three, five
and 10 years. While the trust aims to generate long-term capital
growth, it also pays semi-annual dividends. Based on its current
share price, WWH offers a 0.7% yield.
Click here to view the full report.
All reports published by Edison are available to download free
of charge from its website
www.edisongroup.com
About Edison: Edison is an investment research and advisory
company, with offices in North America, Europe, the Middle East and
AsiaPac. The heart of Edison is our world-renowned equity research
platform and deep multi-sector expertise. At Edison Investment
Research, our research is widely read by international investors,
advisers and stakeholders. Edison Advisors leverages our core
research platform to provide differentiated services including
investor relations and strategic consulting.
Edison is authorised and regulated by the Financial Conduct
Authority .
Edison is not an adviser or broker-dealer and does not provide
investment advice. Edison's reports are not solicitations to buy or
sell any securities.
For more information please contact Edison:
Mel Jenner, +44 (0)20 3077 5720
Sarah Godfrey, +44 (0)20 3681 2519
investmenttrusts@edisongroup.com
Learn more at www.edisongroup.com and connect with Edison on:
LinkedIn https://www.linkedin.com/company/edison-investment-research
Twitter www.twitter.com/Edison_Inv_Res
YouTube www.youtube.com/edisonitv
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRARMMTTMTMJBTM
(END) Dow Jones Newswires
July 30, 2020 08:06 ET (12:06 GMT)
Finsbury Worldwide Pharm (LSE:FWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Finsbury Worldwide Pharm (LSE:FWP)
Historical Stock Chart
From Jul 2023 to Jul 2024